Skip to content

Clinical trials

Phase 4 Fibrosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fibrosis Phase: Phase 4 Clear all

117 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20011
20022
20034
20045
20053
20062
20073
20088
20093
20103
20112
20127
201310
20148
201510
20165
20173
20185
20191
20204
20213
20222
20234
20245
20255
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed62
Unknown status33
Recruiting10
Terminated5
Active, not recruiting2
Not yet recruiting2
Withdrawn2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hospital Clinic of Barcelona4
Korea University4
Medical University of Vienna4
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)4
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau3
Hospital Universitari Vall d'Hebron Research Institute3
Shanghai Changzheng Hospital3
Asian Institute Of Medical Sciences2
Bausch Health Americas, Inc.2
Cairo University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fibrosis117
Hepatic Encephalopathy14
Hypertension, Portal13
Ascites11
Liver Cirrhosis11
Hepatitis C8
Brain Diseases5
Carcinoma, Hepatocellular5
Esophageal and Gastric Varices5
Gastrointestinal Hemorrhage5

Trials

Showing 51 to 75 of 117. Each trial links to its page on Pharma Observatory.

17 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.